Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
15th National Conference of the IAOMFP, Chennai, 2006
Abstracts from current literature
Acne in India: Guidelines for management - IAA Consensus Document
Art & Psychiatry
Association Activities
Association Notes
Award Article
Book Review
Brief Report
Case Analysis
Case Letter
Case Letters
Case Notes
Case Report
Case Reports
Clinical and Laboratory Investigations
Clinical Article
Clinical Studies
Clinical Study
Conference Oration
Conference Summary
Continuing Medical Education
Cosmetic Dermatology
Current Best Evidence
Current Issue
Current View
Derma Quest
Dermato Surgery
Dermatosurgery Specials
Dispensing Pearl
Do you know?
Drug Dialogues
Editor Speaks
Editorial Remarks
Editorial Report
Editorial Report - 2007
Editorial report for 2004-2005
Fourth All India Conference Programme
From Our Book Shelf
From the Desk of Chief Editor
Get Set for Net
Get set for the net
Guest Article
Guest Editorial
How I Manage?
IADVL Announcement
IADVL Announcements
IJDVL Awards
IJDVL Awards 2018
IJDVL Awards 2019
IJDVL Awards 2020
IJDVL International Awards 2018
Images in Clinical Practice
In Memorium
Inaugural Address
Knowledge From World Contemporaries
Leprosy Section
Letter in Response to Previous Publication
Letter to Editor
Letter to the Editor
Letter to the Editor - Case Letter
Letter to the Editor - Letter in Response to Published Article
Letter to the Editor - Observation Letter
Letter to the Editor - Study Letter
Letter to the Editor - Therapy Letter
Letter to the Editor: Articles in Response to Previously Published Articles
Letters in Response to Previous Publication
Letters to the Editor
Letters to the Editor - Letter in Response to Previously Published Articles
Letters to the Editor: Case Letters
Letters to the Editor: Letters in Response to Previously Published Articles
Medicolegal Window
Miscellaneous Letter
Net Case
Net case report
Net Image
Net Letter
Net Quiz
Net Study
New Preparations
News & Views
Observation Letter
Observation Letters
Original Article
Original Contributions
Pattern of Skin Diseases
Pediatric Dermatology
Pediatric Rounds
Presedential Address
Presidential Address
Presidents Remarks
Report of chief editor
Report of Hon : Treasurer IADVL
Report of Hon. General Secretary IADVL
Research Methdology
Research Methodology
Resident page
Resident's Page
Resident’s Page
Residents' Corner
Residents' Corner
Residents' Page
Review Article
Review Articles
Revision Corner
Self Assessment Programme
Seminar: Chronic Arsenicosis in India
Seminar: HIV Infection
Short Communication
Short Communications
Short Report
Special Article
Specialty Interface
Study Letter
Study Letters
Symposium - Contact Dermatitis
Symposium - Lasers
Symposium - Pediatric Dermatoses
Symposium - Psoriasis
Symposium - Vesicobullous Disorders
Symposium Aesthetic Surgery
Symposium Dermatopathology
Symposium-Hair Disorders
Symposium-Nails Part I
Symposium-Nails-Part II
Systematic Review and Meta-Analysis
Systematic Reviews and Meta-analyses
Systematic Reviews and Meta-analysis
Therapeutic Guideline-IADVL
Therapeutic Guidelines
Therapeutic Guidelines - IADVL
Therapy Letter
Therapy Letters
View Point
What’s new in Dermatology
View/Download PDF

Translate this page into:

Letter in Response to Previous Publication
88 (
); 798-799

Authors’ reply

Department of Dermatology, Nirvan Skin Clinic, Vadodara, Gujarat, India
Department of Dermatology, Belle Vue Clinic, Kolkata, West Bengal, India
Department of Dermatology and Laboratory Medicine, Laboratory of Medical Microbiology, Moelbis, Germany
Department of Dermatology and STD, University College of Medical Sciences and GTB Hospital, New Delhi, India
Department of Medical Microbiology, Post Graduate Institute of Medical Education and Research, Chandigarh, India
Department of Dermatology, KPC Medical College and Hospital, Kolkata, West Bengal, India
Department of Dermatology, Venereology and Leprosy, Lady Hardinge Medical College and SSK Hospital, New Delhi, India
Department of Dermatology, Bhojani Clinic, Matunga, Mumbai, India
Corresponding author: Dr. Resham Vasani, Department of Dermatology, Bhojani Clinic, Matunga, Mumbai, India.
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

How to cite this article: Verma SB, Panda S, Nenoff P, Singal A, Rudramurthy SM, Uhrlass S, et al. Authors’ reply. Indian J Dermatol Venereol Leprol 2022;88:798-9.


We thank the correspondent for the interest shown in our article discussing various therapeutic options for the treatment of dermatophytosis.1 The letter has alluded to a specific situation where patients with dermatophytosis are treated with parenteral long-acting steroids with resultant low serum cortisol levels and altered presentation of the disease and asks us to provide a guideline for managing them.2 We presume that the correspondent has read part I of our review where similar observations, but not limited to low serum cortisol levels, have been discussed briefly in the section entitled ‘Iatrogenic Cushingoid syndrome in patients of tinea.’3 However, we have deliberately desisted from attempting to provide management guidelines for parenteral steroid-induced complications, especially those resulting in iatrogenic Cushing syndrome or its incomplete form, because we consider it beyond the dermatologists’ domain and, therefore, not within the broad ambit of the review. In fact, we would consider it imprudent for a dermatologist alone to treat such patients who are in obvious need of an endocrinology referral and would strongly advocate the latter for initial guidance. Questions raised in the letter regarding the method of weaning the patient off steroids, while instituting antifungal therapy, likewise, cannot be answered at present due to the absence of endocrinologists in the team of authors of the review. A lack of published data in the form of well-designed controlled studies makes it difficult to answer questions regarding modification of systemic and topical antifungal regimen. A recently published study describes 23 patients of widespread dermatophytosis with classic symptoms and signs of iatrogenic Cushing syndrome resulting from treatment with oral or parenteral steroids.4 There is also an isolated case report describing the development of iatrogenic Cushing syndrome with erythrodermic tinea corporis in a pediatric patient.5 In both the articles, the emphasis is on the misuse of systemic steroids in the treatment of widespread and recalcitrant dermatophytosis. To the best of our knowledge, there is a glaring dearth of literature regarding management of patients of dermatophytosis presenting with iatrogenic Cushing syndrome that we can cite for the benefit of the readers. Thus, we hold that such situations need to be managed on a case-to-case basis. We recommend an approach including taking detailed history of topical/systemic steroid and antifungal use; measurement of weight, height and blood pressure; a thorough cutaneous and systemic examination; and, routine haematology and biochemical investigations including 8 am and 4 pm serum cortisol levels, plasma glucose levels in fasting state as well as two hours following 75 g of glucose load and serum electrolytes. The dose and duration of antifungal therapy should also be decided on a case-to-case basis, giving due consideration to the age, weight, comorbidities and relevant drugs being given to manage them. Extending the duration of the oral antifungal by at least two weeks and that of topical therapy by at least four weeks beyond clinical clearance is a reasonable approach. Ascertaining mycological clearance is ideal in such cases and should be done whenever feasible. In the case of itraconazole, a longer duration of therapy with due monitoring is more rational than increasing the dose beyond 200 mg/day as the drug follows nonlinear pharmacokinetics and a higher dose logically increases the risk of side-effects.1

At present, measures we consider essential in managing such patients include correcting the underlying hypothalamic-pituitary-adrenal axis suppression in consultation with the endocrinologist, complete avoidance of topical corticosteroids, symptomatic relief with antihistamines, prolonged appropriate antifungal therapy with due monitoring, ensuring compliance to treatment, correction of the underlying comorbid factors, simultaneous treatment of contacts and prevention of fomite spread. We look forward to reading recommendations borne out of well-designed collaborative studies between dermatologists and endocrinologists to manage this subset of patients.

Financial support and sponsorship


Conflicts of interest

There are no conflicts of interest.


  1. , , , , , , et al. The unprecedented epidemic-like scenario of dermatophytosis in India: III. Antifungal resistance and treatment options. Indian J Dermatol Venereol Leprol. 2021;87:468-82.
    [CrossRef] [PubMed] [Google Scholar]
  2. . Need for modification of guidelines for systemic steroid-modified tinea. 2021 doi: 10.25259/IJDVL_956_2021
    [CrossRef] [PubMed] [Google Scholar]
  3. , , , , , , et al. The unprecedented epidemic-like scenario of dermatophytosis in India: I. Epidemiology risk factors and clinical features. Indian J Dermatol Venereol Leprol. 2021;87:154-75.
    [CrossRef] [PubMed] [Google Scholar]
  4. , , , , . Iatrogenic Cushing's syndrome in patients with superficial dermatophytosis. Indian Dermatol Online J. 2021;12:237-43.
    [CrossRef] [PubMed] [Google Scholar]
  5. , , , . Erythrodermic tinea corporis with iatrogenic Cushing's syndrome. Eur J Pediatr Dermatol. 2021;31:178-80.
    [Google Scholar]

Fulltext Views

PDF downloads
View/Download PDF
Download Citations
Show Sections